Donald J. Hayden's most recent trade in Theseus Pharmaceuticals Inc was a trade of 19,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theseus Pharmaceuticals Inc | Donald J. Hayden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Donald J. Hayden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 3,250 | 3,250 | - | - | Restricted Stock Unit | |
| Theseus Pharmaceuticals Inc | Donald J. Hayden | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 29 Dec 2022 | 9,900 | 10,000 | - | 5.0 | 49,489 | Common Stock |
| Theseus Pharmaceuticals Inc | Donald J. Hayden | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 29 Dec 2022 | 100 | 100 | - | 5 | 500 | Common Stock |
| Theseus Pharmaceuticals Inc | Donald J. Hayden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) |